SEL24-B489

CAS No. 1616359-00-2

SEL24-B489( SEL24 )

Catalog No. M12358 CAS No. 1616359-00-2

SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 374 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SEL24-B489
  • Note
    Research use only, not for human use.
  • Brief Description
    SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor.
  • Description
    SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor with Kd of 2/2/3 nM for PIM1/2/3, Kd of 160/16 nM for FLT3-WT/FLT3-ITD, respectively; exhibits significantly broader on-target activity in AML cell lines (MV-4-11 GI50=20 nM) and primary AML blasts than selective FLT3-ITD or PIM inhibitors, decreases viability of AML cells with FLT3-TKD mutations associated with resistance to selective FLT3-ITD inhibitors; inhibits the growth of a broad panel of AML cell lines in xenograft models.Blood Cancer Phase 2 Clinical
  • In Vitro
    In MOLM-13 and to a lesser extent in MV4-11 cells, a dose-dependent disruption of cell cycle with especially pronounced depletion of the S phase after treatment with SEL24-B489, accompanied by PARP cleavage and apoptosis was observed.SEL24-B489 causes a profound inhibition of S6 (S235/236), but has little effect on PI3K/mTOR signaling.SEL24-B489 inhibits STAT5 (Ser726) and reduced expression of MCL1, whereas none of the selective inhibitors altered c-MYC abundance or induced PARP cleavage. Cell Viability AssayCell Line:AZD1208, AC220 and AraC in AML cell lines.Concentration:0-10 μM.Incubation Time:72 h. Result:Decreased viability.
  • In Vivo
    SEL24-B489 (25-100 mg/kg, orally) exhibited activity in AML in vivo models.SEL24-B489 induces apoptosis of DLBCL cell lines in low/sub-micromolar concentrations and exhibits activity in a xenograft model. Animal Model:SCID/beige mice bearing MV-4-11 tumors (FLT3-ITD+).Dosage:50, 75 and 100 mg/kg.Administration:Orally, twice daily.Result:Marked dose – dependent tumor reduction (67%, 74% and 82% tumor growth inhibition (TGI) for 50, 75 and 100 mg/kg daily doses, respectively).
  • Synonyms
    SEL24
  • Pathway
    JAK/STAT Signaling
  • Target
    Pim
  • Recptor
    Pim
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    1616359-00-2
  • Formula Weight
    446.143
  • Molecular Formula
    C15H18Br2N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (56.04 mM)
  • SMILES
    CC(N1C(C2CCNCC2)=NC3=C([N+]([O-])=O)C(Br)=C(Br)C=C31)C.[H]Cl
  • Chemical Name
    5,6-dibromo-4-nitro-2-(piperidin-4-yl)-1-(propan-2-yl)-1H-1,3-benzodiazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Czardybon W, et al. Oncotarget. 2018 Mar 30;9(24):16917-16931. 2. Bia?opiotrowicz E, et al. J Cell Mol Med. 2018 Apr 17. doi: 10.1111/jcmm.13632. 3. Szyd?owski M, et al. Blood. 2017 Sep 21;130(12):1418-1429.
molnova catalog
related products
  • Pim1/AKK1-IN-1

    A potent, multikinase inhibitor and also inhibits MPSK1 and TNIK.

  • K00135

    K00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.

  • Taprenepag

    Taprenepag (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM).